Related Experiment Video

Updated: Jun 16, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Mycoplasma pneumonia and its complications

Leon G Smith1

  • 1Infectious Disease Foundation of Saint Michael's Medical Center, 111 Central Avenue, Newark, NJ 07102, USA. lgsmithmd@aol.com

Infectious Disease Clinics of North America
|February 23, 2010
PubMed

Insights

Mycoplasma pneumoniae causes atypical pneumonia, but effective antibiotics exist. Early detection of extrapulmonary Mycoplasma pneumoniae is crucial for managing this infection and preventing potential complications.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Mycoplasma pneumoniae is a leading cause of atypical pneumonia.
  • Extrapulmonary manifestations of M. pneumoniae infection require specialized diagnostic skills.
  • The efficacy of early therapeutic interventions in preventing severe complications remains unclear.

Purpose of the Study:

  • To review the current understanding of Mycoplasma pneumoniae infections.
  • To highlight the importance of recognizing extrapulmonary M. pneumoniae disease.
  • To discuss the role of antibiotics in treating M. pneumoniae.

Main Methods:

  • Literature review of Mycoplasma pneumoniae diagnosis and treatment.
  • Analysis of clinical presentations of atypical pneumonia.
  • Synthesis of information on extrapulmonary manifestations.

Main Results:

  • Antibiotic therapy is generally effective for M. pneumoniae infections.
  • Diagnosing extrapulmonary M. pneumoniae requires heightened clinical awareness.
  • Optimal timing for treatment to prevent complications is not established.

Conclusions:

  • Mycoplasma pneumoniae remains a significant respiratory pathogen.
  • Prompt and accurate diagnosis, including extrapulmonary forms, is essential.
  • Further research is needed to determine the impact of early treatment on long-term outcomes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.